26 Recruiting Studies Using Amivantamab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Amivantamab
PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer
📍 MD Anderson Cancer Center — Houston, Texas
Non-small Cell Lung Cancer
View Study & Checklist ➔A Study of Amivantamab in People With Esophagogastric Cancer
📍 University of California, Irvine — Irvine, California
Esophagogastric Cancer
View Study & Checklist ➔A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions
📍 City of Hope 2 — Duarte, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
📍 City of Hope Duarte — Duarte, California
Advanced or Metastatic Non-small Cell Lung Cancer
View Study & Checklist ➔A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
📍 Sarah Cannon Research Institute at HealthONE — Denver, Colorado
Solid Tumor, Adult
View Study & Checklist ➔A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer
📍 University of Alabama at Birmingham, Comprehensive Cancer Center — Birmingham, Alabama
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
📍 Clinical Research Facility — Duarte, California
Non-Small-Cell Lung Cancer
View Study & Checklist ➔Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
📍 Ironwood Cancer and Research Center — Chandler, Arizona
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer
📍 City of Hope — Duarte, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Premedication to Reduce Amivantamab Associated Infusion Related Reactions
📍 Compassionate Cancer Care — Fountain Valley, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
📍 Arizona Oncology Associates, PC - HAL — Goodyear, Arizona
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
📍 City of Hope Cancer Center — Duarte, California
Lung Cancer
View Study & Checklist ➔A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
📍 Southern Cancer Center, PC — Mobile, Alabama
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Amivantamab in Adenoid Cystic Carcinoma
📍 UC San Diego Moores Cancer Center — La Jolla, California
Salivary Gland Cancer
View Study & Checklist ➔A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
📍 University of California at San Diego Moores Cancer Center — La Jolla, California
Squamous Cell Carcinoma of Head and Neck
View Study & Checklist ➔Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Locally Recurrent Skin Squamous Cell Carcinoma
View Study & Checklist ➔Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
📍 NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro — Jonesboro, Arkansas
Lung Non-Small Cell Carcinoma
View Study & Checklist ➔A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Colorectal Neoplasms
View Study & Checklist ➔A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
📍 Southern Cancer Center, PC — Daphne, Alabama
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
📍 Ironwood Cancer and Research Center — Chandler, Arizona
Squamous Cell Carcinoma of Head and Neck
View Study & Checklist ➔A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
📍 New York University Langone Medical Center — New York, New York
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
📍 City of Hope — Duarte, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
📍 O Neal Comprehensive Cancer Center at UAB — Birmingham, Alabama
Advanced or Metastatic Colorectal Cancer
View Study & Checklist ➔A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
📍 University of California at San Diego — La Jolla, California
Carcinoma, Non-small-Cell Lung
View Study & Checklist ➔A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
📍 Ironwood Cancer and Research Center — Chandler, Arizona
Colorectal Neoplasms
View Study & Checklist ➔